William T. Abraham, MD
Deepak L. Bhatt, MD
Charles Kinder, MD

Release date: April 25, 2014
Expiration date: April 30, 2015

Program Overview
This online activity, based on a live meeting held on November 17, 2013 in Dallas, TX, will educate cardiology fellows and others interested in the emerging standard of care for patients with high risk in the early post-MI period. Despite PCI therapy after MI, a significant cohort of patients remains with residual high risk for CV events, including those with T2DM, bleeding risks, low EF, LV dyssynchrony, and arrhythmias. This engaging program will review special management considerations for pharmacologic and device therapy using the current knowledge base to optimize care and avoid adverse events.

Target Audience
Cardiology Fellows, young-in-practice Cardiologists, and other healthcare professionals involved in the care of patients early post-MI


William T. Abraham, MD, FACP, FACC, FAHA, FESC
Professor of Medicine, Physiology, and Cell Biology
Chair of Excellence in Cardiovascular Medicine
Director, Division of Cardiovascular Medicine
Deputy Director, Davis Heart and Lung Research Institute
The Ohio State University
Columbus, OH

Dr. Abraham is Professor of Medicine, Physiology, and Cell Biology, Chair of Excellence in Cardiovascular Medicine, Director of the Division of Cardiovascular Medicine, and Deputy Director of the Davis Heart and Lung Research Institute at The Ohio State University in Columbus, OH. He earned his medical degree at Harvard Medical School, completed his internship and residency in Medicine at the University of Colorado Health Sciences Center, and completed fellowships in Cardiology, Transplant Cardiology, and Research Cardiology at the University of Colorado Health Sciences Center and in Heart Failure/Cardiac Transplantation at the University of Utah. His research and clinical interests include heart failure, cardiac transplantation, cardiac resynchronization therapy, neurohormonal mechanisms, and clinical drug and device trials. He is a Diplomate of the American Board of Internal Medicine, Cardiovascular Disease and the National Board of Medical Examiners. Dr. Abraham has been published in numerous peer-reviewed journals, including the Journal of the American College of Cardiology, Circulation, and the New England Journal of Medicine.

Deepak L. Bhatt, MD, MPH, FAHA, FACC
Chief of Cardiology, VA Boston Healthcare System
Senior Physician, Brigham & Women’s Hospital
Professor, Harvard Medical School
Boston, MA

Dr. Bhatt is Chief of Cardiology at the VA Boston Healthcare System, a Senior Physician at Brigham and Women’s Hospital, and a Professor at Harvard Medical School in Boston, MA. He earned his medical degree at Weill Medical College of Cornell University and completed his internship and residency in Internal Medicine at the Hospital of the University of Pennsylvania and fellowships in Cardiology and Interventional Cardiology at the Cleveland Clinic. He also earned an MPH degree from the Harvard School of Public Health. His clinical and research interests include preventive cardiology, antithrombotic medications, optimal management of patients with acute coronary syndromes, and advanced techniques in cardiac, cerebral, and peripheral interventions. Dr. Bhatt is the Editor-in-Chief of the Harvard Heart letter and a principal investigator on a number of clinical trials. He has been published in numerous peer-reviewed journals, including New England Journal of Medicine, Lancet, and Journal of the American Medical Association.

Charles Kinder, MD
Founder and Director
Heart Care Centers Heart Rhythm Program
Heart Care Centers of Illinois
Chicago, IL

Dr. Kinder is the Founder and Director of the Heart Care Centers Heart Rhythm Program in Chicago, IL. He earned his medical degree at the University of Illinois College of Medicine and completed his internship and residency in Internal Medicine at Brigham and Women's Hospital and a Cardiology fellowship at Loyola University Medical Center. Dr. Kinder completed his Heart Rhythm (Clinical Cardiac Electrophysiology) training at the University of Chicago. He has implanted more than 8000 pacemakers/defibrillators, including more than 2000 biventricular devices. He has performed more than 3000 radio frequency catheter ablation procedures to cure rapid heart rhythm disorders. Dr. Kinder is recognized as an expert in the heart rhythm field and serves as a faculty member for HRS, ACC, and AHA educational programs. He has defended hospitals in the DOJ ICD investigation. He is also on the Board of Directors of the HRS Consulting Services Company.

Fee Information
There is no fee for this online activity.

For additional information, contact carchibald@medtelligence.net

Examining Risk in Patients with Acute Myocardial Infarction
William T. Abraham, MD
Managing the Risk Post PCI: Restenosis, Thrombosis, and Advances in Dual Antiplatelet Therapy
Deepak L. Bhatt, MD
Initial Management of Post-MI Sudden Death Risk
Charles Kinder, MD

The material presented here does not necessarily reflect the views of Medtelligence, or companies that support educational programming on http://events.medtelligence.net. These materials may discuss therapeutic products that have not been approved by the US Food and Drug Administration and off-label uses of approved products. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or employing any therapies described in these educational activities.